REG - CVS Group plc - Changes to NEDs' Responsibilities

CVSAnnouncement

Today 07:02

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260526:nRSZ6171Fa&default-theme=true

RNS Number : 6171F  CVS Group plc  26 May 2026

 
 
 
 

26 May 2026

 

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

 

Changes to Non-Executive Director Responsibilities

 

CVS, the UK listed veterinary group and a leading provider of veterinary
services, is pleased to announce a change in responsibilities for one of the
recently appointed Non-Executive Directors.

 

Laura Hagan, Independent Non-Executive Director, will be appointed as Senior
Independent Director and Employee Engagement Director with effect from 1 July
2026.

 

Laura succeeds Deborah Kemp, who will step down from the roles of Senior
Independent Director, Employee Engagement Director and Remuneration Committee
Chair with effect from 30 June 2026. As previously announced, Deborah, who
joined the Board in January 2018, will retire and step down from the Board and
all board committees on that date.

 

Helen Keays, Independent Non-Executive Director and Chair designate of the
Remuneration Committee, will become Chair of the Remuneration Committee with
effect from 1 July 2026.

 

This announcement is made pursuant to UKLR 6.4.6.

 

 

 Contacts

 CVS Group plc                                               via FGS Global

 Richard Fairman, Chief Executive Officer

 Scott Morrison, Group Legal Counsel and Company Secretary

 

 FGS Global           +44 (0)207 251 3801
 Faeth Birch          cvsgroup@fgsglobal.com

 Charlie Chichester

 

 

About CVS Group plc (www.cvsukltd.co.uk)

CVS Group is a leading provider of veterinary services, operating in the UK
and Australia, listed on the Main Market of the London Stock Exchange. CVS is
focused on providing high-quality clinical services to its clients and their
animals, with outstanding and dedicated clinical teams and support colleagues
at the core of its strategy.

 

The Group operates over 475 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").

 

The Group employs 9,000 personnel, including 2,500 veterinary surgeons and
3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCBCGDURSDDGLU



            Copyright 2019 Regulatory News Service, all rights reserved